Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-09-23

FDA Approved: COZAAR — Supplemental Application (Organon LLC)

View source ↗

Summary

The FDA approved a supplemental application for Cozaar (losartan potassium) from Organon LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cozaar (losartan)

Snippet

SUPPL AP for COZAAR (LOSARTAN POTASSIUM)